Get started
Biomerica, Inc.Biomerica, Inc.Biomerica, Inc.

Biomerica, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

BMRA chart


Full chart

BMRA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪5.44 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.3663 USD
Net income (FY)
‪−5.98 M‬ USD
Revenue (FY)
‪5.42 M‬ USD
Shares float
‪15.61 M‬
Beta (1Y)
1.16

Employees


Employees (FY)
64
Change (1Y)
+2 +3.23%
Revenue / Employee (1Y)
‪84.61 K‬ USD
Net income / Employee (1Y)
‪−93.41 K‬ USD

About Biomerica, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Zackary S. Irani
Website
biomerica.com
Headquarters
Irvine
Founded
1971
FIGI
BBG000BDH8F6
Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

BMRA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of BMRA is 0.3140 USD — it has decreased by −0.25% in the past 24 hours. Watch Biomerica, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Biomerica, Inc. stocks are traded under the ticker BMRA.
BMRA stock has fallen by −10.14% compared to the previous week, the month change is a −0.46% fall, over the last year Biomerica, Inc. has showed a −63.49% decrease.
BMRA reached its all-time high on Nov 12, 1980 with the price of 24.3335 USD, and its all-time low was 0.1700 USD and was reached on Jan 6, 2003. View more price dynamics on BMRA chart.
See other stocks reaching their highest and lowest prices.
BMRA stock is 8.52% volatile and has beta coefficient of 1.16. Track Biomerica, Inc. stock price on the chart and check out the list of the most volatile stocks — is Biomerica, Inc. there?
Today Biomerica, Inc. has the market capitalization of ‪5.44 M‬, it has decreased by −7.33% over the last week.
Yes, you can track Biomerica, Inc. financials in yearly and quarterly reports right on TradingView.
Biomerica, Inc. is going to release the next earnings report on Jan 21, 2025. Keep track of upcoming events with our Earnings Calendar.
BMRA net income for the last quarter is ‪−1.32 M‬ USD, while the quarter before that showed ‪−1.42 M‬ USD of net income which accounts for 7.39% change. Track more Biomerica, Inc. financial stats to get the full picture.
No, BMRA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 64.00 employees. See our rating of the largest employees — is Biomerica, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Biomerica, Inc. EBITDA is ‪−6.13 M‬ USD, and current EBITDA margin is −110.67%. See more stats in Biomerica, Inc. financial statements.
Like other stocks, BMRA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Biomerica, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Biomerica, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Biomerica, Inc. stock shows the sell signal. See more of Biomerica, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.